Regatta Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Regatta Capital Group's BMY Position: Q3 2026 in Review
Regatta Capital Group increased its Bristol-Myers Squibb (BMY) stake by 4% in Q3 2026, buying an estimated $10.4K and bringing the position to 4,255 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #193.
Regatta Capital Group first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $586K in Q3 2022. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Regatta Capital Group held 4,255 shares of Bristol-Myers Squibb worth $266K as of Q3 2026.
- Regatta Capital Group bought 164 Bristol-Myers Squibb shares in Q3 2026, an estimated $10.4K.
- Bristol-Myers Squibb made up 0.03% of Regatta Capital Group's portfolio in Q3 2026, its #193 holding.
- Regatta Capital Group first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- Regatta Capital Group's Bristol-Myers Squibb position peaked at $586K in Q3 2022.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Regatta Capital Group's 13F filing for Q3 2026, filed 23 Oct 2026.